A systems biology approach to discovering pathway signaling dysregulation in metastasis
暂无分享,去创建一个
Yue Wang | Robert Clarke | Pavel Kraikivski | Brandon C. Jones | Catherine M. Sevigny | Surojeet Sengupta | R. Clarke | P. Kraikivski | Yue Wang | S. Sengupta | Catherine M Sevigny | Catherine M. Sevigny
[1] Robert Clarke,et al. UNDO: a Bioconductor R package for unsupervised deconvolution of mixed gene expressions in tumor samples , 2015, Bioinform..
[2] Ali Najafi,et al. Cancer systems biology and modeling: microscopic scale and multiscale approaches. , 2015, Seminars in cancer biology.
[3] Jason W. Locasale,et al. Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing , 2020, Nature Cell Biology.
[4] Jonathan R. Karr,et al. A Whole-Cell Computational Model Predicts Phenotype from Genotype , 2012, Cell.
[5] S. Elmore. Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.
[6] Eduard Batlle,et al. Transforming Growth Factor-β Signaling in Immunity and Cancer. , 2019, Immunity.
[7] E. Gehan,et al. The properties of high-dimensional data spaces: implications for exploring gene and protein expression data , 2008, Nature Reviews Cancer.
[8] K. Lamperska,et al. 2D and 3D cell cultures – a comparison of different types of cancer cell cultures , 2016, Archives of medical science : AMS.
[9] Peter C. Searson,et al. In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform , 2016, Front. Bioeng. Biotechnol..
[10] Ryung S. Kim,et al. Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer , 2012, PloS one.
[11] D. Lauffenburger,et al. Modeling a Snap-Action, Variable-Delay Switch Controlling Extrinsic Cell Death , 2008, PLoS biology.
[12] Antonio Reverter,et al. A Differential Wiring Analysis of Expression Data Correctly Identifies the Gene Containing the Causal Mutation , 2009, PLoS Comput. Biol..
[13] Katherine C. Chen,et al. Integrative analysis of cell cycle control in budding yeast. , 2004, Molecular biology of the cell.
[14] Katherine C. Chen,et al. Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell. , 2003, Current opinion in cell biology.
[15] F. J. Geske,et al. Early stages of p53-induced apoptosis are reversible , 2001, Cell Death and Differentiation.
[16] John J Tyson,et al. A model for restriction point control of the mammalian cell cycle. , 2004, Journal of theoretical biology.
[17] Pavel Kraikivski,et al. Computational Model of G2-M DNA Damage Checkpoint Regulation in Normal and p53-null Cancer Cells , 2020, bioRxiv.
[18] Ronald J. Moore,et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer , 2016, Cell.
[19] Yibin Kang,et al. Unravelling the complexity of metastasis — molecular understanding and targeted therapies , 2011, Nature Reviews Cancer.
[20] T. M. Murali,et al. Modeling and analysis of the macronutrient signaling network in budding yeast , 2020, bioRxiv.
[21] Quy H. Nguyen,et al. Experimental Considerations for Single-Cell RNA Sequencing Approaches , 2018, Front. Cell Dev. Biol..
[22] S. Lipton,et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 , 2018, Cell Death & Differentiation.
[23] P. Friedl,et al. Classifying collective cancer cell invasion , 2012, Nature Cell Biology.
[24] S. Narod,et al. Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence , 2007, Clinical Cancer Research.
[25] Robert Clarke,et al. Systems biology: perspectives on multiscale modeling in research on endocrine-related cancers. , 2019, Endocrine-related cancer.
[26] W. Baumann,et al. Dynamic Modeling of the Interaction Between Autophagy and Apoptosis in Mammalian Cells , 2013, CPT: pharmacometrics & systems pharmacology.
[27] J. Tyson,et al. A simple model of circadian rhythms based on dimerization and proteolysis of PER and TIM. , 1999, Biophysical journal.
[28] N. Dimitrova,et al. InFlo: a novel systems biology framework identifies cAMP-CREB1 axis as a key modulator of platinum resistance in ovarian cancer , 2016, Oncogene.
[29] Sarah J. Parker,et al. Proteomic Architecture of Human Coronary and Aortic Atherosclerosis , 2018, Circulation.
[30] S. Sleijfer,et al. The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies , 2019, Nature Genetics.
[31] E. Hoffman,et al. Mathematical modelling of transcriptional heterogeneity identifies novel markers and subpopulations in complex tissues , 2016, Scientific Reports.
[32] Zhongming Zhao,et al. Transcriptome- and proteome-oriented identification of dysregulated eIF4G, STAT3, and Hippo pathways altered by PIK3CAH1047R in HER2/ER-positive breast cancer , 2016, Breast Cancer Research and Treatment.
[33] Francisco Avila Cobos,et al. Computational deconvolution of transcriptomics data from mixed cell populations , 2018, Bioinform..
[34] E. Andres Houseman,et al. Reference-free deconvolution of DNA methylation data and mediation by cell composition effects , 2016, BMC Bioinformatics.
[35] James C. Whisstock,et al. Perforin and granzymes: function, dysfunction and human pathology , 2015, Nature Reviews Immunology.
[36] K. Hunter,et al. Genetic insights into the morass of metastatic heterogeneity , 2018, Nature Reviews Cancer.
[37] Benjamin J. Raphael,et al. Pan-Cancer Network Analysis Identifies Combinations of Rare Somatic Mutations across Pathways and Protein Complexes , 2014, Nature Genetics.
[38] Weiqing Wang,et al. Perturbation Biology: Inferring Signaling Networks in Cellular Systems , 2013, PLoS Comput. Biol..
[39] J. Ferrell,et al. Modeling the Cell Cycle: Why Do Certain Circuits Oscillate? , 2011, Cell.
[40] Jen-Huang Huang,et al. Plug-and-Play In Vitro Metastasis System toward Recapitulating the Metastatic Cascade , 2019, Scientific Reports.
[41] Sridhar Ramaswamy,et al. Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis , 2014, Cell.
[42] E. Ruppin,et al. Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism , 2010, Molecular systems biology.
[43] E. Marcotte,et al. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses , 2012, Nature Reviews Genetics.
[44] John J Tyson,et al. A Dynamical Paradigm for Molecular Cell Biology. , 2020, Trends in cell biology.
[45] Kohei Miyazono,et al. TGFβ signalling: a complex web in cancer progression , 2010, Nature Reviews Cancer.
[46] Maw-Shang Chang,et al. Dynamic sensitivity analysis of biological systems , 2008, BMC Bioinformatics.
[47] Robert Clarke,et al. Differential dependency network analysis to identify condition-specific topological changes in biological networks , 2009, Bioinform..
[48] Christopher J Tape,et al. Systems Biology Analysis of Heterocellular Signaling. , 2016, Trends in biotechnology.
[49] Paul Brazhnik,et al. Computational analysis of dynamical responses to the intrinsic pathway of programmed cell death. , 2009, Biophysical journal.
[50] Christina H. Stuelten,et al. Cell motility in cancer invasion and metastasis: insights from simple model organisms , 2018, Nature Reviews Cancer.
[51] Daniel B. Forger,et al. A mechanism for robust circadian timekeeping via stoichiometric balance , 2012, Molecular systems biology.
[52] R. Clarke,et al. Approaches to working in high-dimensional data spaces: gene expression microarrays , 2008, British Journal of Cancer.
[53] Johannes G. Reiter,et al. An analysis of genetic heterogeneity in untreated cancers , 2019, Nature Reviews Cancer.
[54] Jonathan W. Uhr,et al. Controversies in clinical cancer dormancy , 2011, Proceedings of the National Academy of Sciences.
[55] T M Murali,et al. From START to FINISH: computational analysis of cell cycle control in budding yeast , 2015, npj Systems Biology and Applications.
[56] Katherine C. Chen,et al. Kinetic analysis of a molecular model of the budding yeast cell cycle. , 2000, Molecular biology of the cell.
[57] Robert A Gatenby,et al. Application of Evolutionary Principles to Cancer Therapy. , 2015, Cancer research.
[58] Brendan F. Kohrn,et al. Extensive subclonal mutational diversity in human colorectal cancer and its significance , 2019, Proceedings of the National Academy of Sciences.
[59] Andrea Califano,et al. ARACNe-AP: gene network reverse engineering through adaptive partitioning inference of mutual information , 2016, Bioinform..
[60] Ioannis Xenarios,et al. A method for the generation of standardized qualitative dynamical systems of regulatory networks , 2005, Theoretical Biology and Medical Modelling.
[61] Robert Clarke,et al. Dynamic modelling of oestrogen signalling and cell fate in breast cancer cells , 2011, Nature Reviews Cancer.
[62] Jonathan R. Karr,et al. Accelerated discovery via a whole-cell model , 2013, Nature Methods.
[63] Mohit Kumar Jolly,et al. Epithelial/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding? , 2017, Molecular oncology.
[64] Randy Heiland,et al. A Review of Cell-Based Computational Modeling in Cancer Biology , 2019, JCO clinical cancer informatics.
[65] Yunyun Zhou,et al. An epigenetically distinct breast cancer cell subpopulation promotes collective invasion. , 2015, The Journal of clinical investigation.
[66] S. Adams,et al. Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review. , 2016, JAMA oncology.
[67] Albert Goldbeter,et al. Temporal self-organization of the cyclin/Cdk network driving the mammalian cell cycle , 2009, Proceedings of the National Academy of Sciences.
[68] Thomas R. Cox,et al. Pre-metastatic niches: organ-specific homes for metastases , 2017, Nature Reviews Cancer.
[69] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[70] Jingyu Zhang,et al. TGF-β–induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops , 2014, Science Signaling.
[71] Matteo Barberis,et al. Quantitative Systems Biology to decipher design principles of a dynamic cell cycle network: the “Maximum Allowable mammalian Trade–Off–Weight” (MAmTOW) , 2017, npj Systems Biology and Applications.
[72] C. Sander,et al. Models from experiments: combinatorial drug perturbations of cancer cells , 2008, Molecular systems biology.
[73] Andrea Califano,et al. A Systems Approach to Drug Discovery in Alzheimer’s Disease , 2014, Neurotherapeutics.
[74] Sookkyung Lim,et al. Mathematical modeling and validation of glucose compensation of the neurospora circadian clock. , 2015, Biophysical journal.
[75] Yahia Adnani,et al. Genomic characterization of metastatic breast cancers , 2019, Nature.
[76] John J Tyson,et al. Modeling the dynamic behavior of biochemical regulatory networks. , 2019, Journal of theoretical biology.
[77] B. Kholodenko,et al. Control analysis of glycolytic oscillations. , 1996, Biophysical chemistry.
[78] Xiao-ming Meng,et al. TGF-β: the master regulator of fibrosis , 2016, Nature Reviews Nephrology.
[79] G. Pearson,et al. Control of Invasion by Epithelial-to-Mesenchymal Transition Programs during Metastasis , 2019, Journal of clinical medicine.
[80] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[81] Benjamin J. Raphael,et al. Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin , 2014, Cell.
[82] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.